Engineered nanomaterial captures off-target cancer drug to prevent tissue damage
Standard chemotherapies may efficiently kill cancer cells, but they also pose significant risks to healthy cells, resulting in secondary illness and a diminished quality of life for patients. To prevent the previously unavoidable damage, researchers have developed a new class of nanomaterials engineered to capture chemotherapy drugs before they interact with healthy tissue.
Materials provided by Penn State. Original written by Ashley Wenners Herron. Note: Content may be edited for style and length.
Source link aaaaa